InvestorsHub Logo

McMagyar

05/31/17 8:47 AM

#106633 RE: nidan7500 #106630

Nidan.
This is the dilemma is it not?
If the evidence is stacking up all around you, and you are now quiet as a mouse..

Based on Epilepsy Plus Patent app
It appears as though Anavex sees itself as not only a great prophylactic drug but as a tremendous Adjunct for this drugs that already target a specific malady. Which makes sense since there are Sigma 1 Ligand Cells all over the body. If a stud already targets an area add some Homeostasis and watch the miracles!

But if you KNOW you have this..
Don't you try to lock in as much
Intellectual Property Rights
Before you share that news?

Guys I think we are in a competitive marketplace quiet period.


Shhh

kld2

05/31/17 9:57 AM

#106635 RE: nidan7500 #106630

So tired of hearing this story. Let's see data. I'm beginning to think Missling is the biotech emperor who wore no clothes.